Cargando…

Increased MCL–1 Expression Is Associated with Poor Prognosis in Ovarian Carcinomas

To investigate the potential role of the BCL–2 gene family (BAX, BCL–2, MCL–1, and BCL‐XL) in ovarian cancer development and progression, mRNA expression levels of these genes were measured using semi‐quantitative PCR in epithelial ovarian tumor tissues and normal ovaries. The immunohistochemical ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shigemasa, Kazushi, Katoh, Osamu, Shiroyama, Yuko, Mihara, Shoji, Mukai, Keiji, Nagai, Nobutaka, Ohama, Koso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2002
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927039/ https://www.ncbi.nlm.nih.gov/pubmed/12036450 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01289.x

Ejemplares similares

Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia
por: Li, Xi-xi, et al.
Publicado: (2019)

Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers
por: Palve, Vinayak, et al.
Publicado: (2014)

Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer
por: Qian, Hua, et al.
Publicado: (2019)

Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis
por: Liu, Hui, et al.
Publicado: (2020)

Mcl-1 is a key regulator of the ovarian reserve
por: Omari, S, et al.
Publicado: (2015)

Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
por: Yasuoka, Hidetaka, et al.
Publicado: (2020)

Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1
por: Ishii, Norihiro, et al.
Publicado: (2017)

The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Su, Yu-Chu, et al.
Publicado: (2021)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019)

Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer
por: Matsubara, Yuko, et al.
Publicado: (2019)

Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma
por: Zaitsu, Sumika, et al.
Publicado: (2023)

Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients
por: Tang, Yaoxiang, et al.
Publicado: (2021)

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer
por: Váncza, Lóránd, et al.
Publicado: (2023)

Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer
por: Ma, Zebiao, et al.
Publicado: (2017)

Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021)

Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis
por: Yamasaki, Koji, et al.
Publicado: (2018)

BMP-2 signaling in ovarian cancer and its association with poor prognosis
por: Le Page, Cécile, et al.
Publicado: (2009)

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
por: Labidi-Galy, Sana Intidhar, et al.
Publicado: (2012)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer
por: Phippen, Neil T., et al.
Publicado: (2016)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

Overexpression of PRC1 indicates a poor prognosis in ovarian cancer
por: Bu, Hualei, et al.
Publicado: (2020)

GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer
por: Huang, Yan, et al.
Publicado: (2021)

The POSEIDON stratification - moving from poor ovarian response to low prognosis
por: Roque, Matheus, et al.
Publicado: (2021)

Plasma exosomal caveolin-1 predicts Poor Prognosis in Ovarian Cancer
por: Yang, Lijuan, et al.
Publicado: (2021)

High BMP7 expression is associated with poor prognosis in ovarian cancer
por: Vasan, Richa, et al.
Publicado: (2023)

Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells
por: Pervin, S, et al.
Publicado: (2011)

Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapy
por: Yokohama, Keisuke, et al.
Publicado: (2020)

Differential PAX5 levels promote malignant B cell infiltration, progression and drug resistance and predict a poor prognosis in MCL patients independent of CCND1
por: Teo, Albert E., et al.
Publicado: (2015)

YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2014)

The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer
por: Stewart, Michelle L., et al.
Publicado: (2010)

Outcomes Following ACL and Grade III MCL Injuries: Is there a Role for MCL Repair?
por: Westermann, Robert W., et al.
Publicado: (2017)

PorthoMCL: Parallel orthology prediction using MCL for the realm of massive genome availability
por: Tabari, Ehsan, et al.
Publicado: (2017)

Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021)

Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma
por: Watanabe, Akira, et al.
Publicado: (2014)

Which Fibers of the Medial Collateral Ligament (MCL) Should Be Released in the Pie Crust Technique Applied During Knee Arthroscopy: Superficial MCL or Deep MCL?
por: Arıcan, Gökhun, et al.
Publicado: (2021)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?
por: Vidal, Fabien, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_96uolj3s0bdl3vups9gin3lqh0